These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6323321)

  • 1. Antibacterial activity and kill kinetics of ampicillin/sulbactam (CP-45899) combinations against Escherichia coli and Klebsiella aerogenes.
    Fuglesang JE; Bergan T
    Infection; 1984; 12(1):46-50. PubMed ID: 6323321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.
    Fuglesang JE; Bergan T
    Infection; 1983; 11(6):329-35. PubMed ID: 6365790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin tazobactam compared with co-amoxiclav, ampicillin plus sulbactam and timentin against beta-lactamase-producing clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Traub WH; Leonhard B
    Chemotherapy; 1995; 41(5):345-52. PubMed ID: 8521736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniae.
    Shungu DL; Ponticas S; Gill CJ
    Clin Ther; 1989; 11(3):315-8. PubMed ID: 2663161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S; Marre R
    Infection; 1991; 19(2):106-9. PubMed ID: 1646771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulbactam: biochemical factors involved in its synergy with ampicillin.
    Labia R; Morand A; Lelievre V; Mattioni D; Kazmierczak A
    Rev Infect Dis; 1986; 8 Suppl 5():S496-502. PubMed ID: 3025996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
    Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
    Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ; Ponticas S; Shungu DL; Guerriero S
    Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.
    Retsema JA; English AR; Girard AE
    Antimicrob Agents Chemother; 1980 Apr; 17(4):615-22. PubMed ID: 6249192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.
    Kazmierczak A; Duez JM; Pechinot A; Nordmann P; Labia R
    Rev Infect Dis; 1986; 8 Suppl 5():S549-54. PubMed ID: 3026003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of susceptibility testing methods for ampicillin-sulbactam using a panel of beta-lactamase-producing bacteria.
    Siu LK; Lo JY; Cheng WL; Ho PL; Ng WS; Chau PY
    APMIS; 1999 Jul; 107(7):703-8. PubMed ID: 10440070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
    Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
    Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinetics of the antibacterial effect of ampicillin and sulbactam combinations in dynamic and static conditions].
    Nazarov AD; Chernykh VM; Samoĭlova LN; Treskina OS; Firsov AA
    Antibiot Khimioter; 1989 Sep; 34(9):669-77. PubMed ID: 2514630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.
    Firsov AA; Saverino D; Ruble M; Gilbert D; Manzano B; Medeiros AA; Zinner SH
    Antimicrob Agents Chemother; 1996 Mar; 40(3):734-8. PubMed ID: 8851602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
    Naber KG; Wittenberger R
    Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological properties of sulbactam combined with ampicillin.
    Barba D; Galante D; Esposito S; Ruffilli MP
    Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.